These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10240143)

  • 21. Medico-legal bulletin number 254: Drug package inserts.
    DeMarco FJ
    Med Leg Bull; 1974 Jun; 23(6):1-6. PubMed ID: 4846844
    [No Abstract]   [Full Text] [Related]  

  • 22. Mandatory PPIs to begin in 1981; APhA issues strong objections.
    Small WE
    Am Pharm; 1980 Nov; NS20(11):10-1. PubMed ID: 7457342
    [No Abstract]   [Full Text] [Related]  

  • 23. Workshop on conflicting guidelines for the use of vaccines.
    Halsey NA; Hall CB
    Pediatrics; 1995 Jun; 95(6):938-41. PubMed ID: 7761228
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA proposes that patient package insert program be rescinded.
    Hospitals; 1982 Feb; 56(4):84. PubMed ID: 7054117
    [No Abstract]   [Full Text] [Related]  

  • 25. Patient package inserts--a good idea gone bad.
    Kough RH
    Pa Med; 1978 Jul; 81(7):15-6. PubMed ID: 662407
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmaceutical inserts: legal consequences.
    Hirsh HL
    Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric priorities: legislative and regulatory initiatives to expand research on the use of medicines in pediatric patients.
    Labson MS
    J Health Care Law Policy; 2002; 6(1):34-72. PubMed ID: 15017951
    [No Abstract]   [Full Text] [Related]  

  • 28. Patient package inserts-an industry viewpoint.
    Waife SO
    Trans Stud Coll Physicians Phila; 1977 Jul; 45(1):4-7. PubMed ID: 617242
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient package inserts and the pharmacist's responsibility.
    Fink JL
    Am J Hosp Pharm; 1979 Feb; 36(2):226-9. PubMed ID: 420215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The package insert and the pharmacist's liability.
    Simonsmeier LM
    Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA proposes patient package inserts for most drugs.
    Mayberger HW; Bell BJ
    Leg Aspects Med Pract; 1979 Oct; 7(10):42-4. PubMed ID: 263192
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient package inserts: a symposium. Introduction.
    Barclay WR
    Trans Stud Coll Physicians Phila; 1977 Jul; 45(1):2-3. PubMed ID: 617240
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA commissioner discusses issues of concern to hospital pharmacists. Interview by William A. Zellmer.
    Goyan JE
    Am J Hosp Pharm; 1980 May; 37(5):738-40 contd. PubMed ID: 7386484
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO
    Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
    [No Abstract]   [Full Text] [Related]  

  • 35. Plans to restrict 'extra-label' use of cephalosporins in the USA.
    Vet Rec; 2012 Feb; 170(6):142. PubMed ID: 22331777
    [No Abstract]   [Full Text] [Related]  

  • 36. Patient package inserts: the patient's right to know.
    Kruger ID
    Bull Am Coll Physicians; 1977 Jan; 18(1):18-9. PubMed ID: 10235933
    [No Abstract]   [Full Text] [Related]  

  • 37. Fourteen fallacies about patient package inserts.
    Goyan J
    West J Med; 1981 May; 134(5):463-8. PubMed ID: 7257361
    [No Abstract]   [Full Text] [Related]  

  • 38. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 39. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient package inserts: goals versus achievements.
    Lasagna L
    Drug Ther; 1982; ():181-9. PubMed ID: 7105992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.